Article Text

This article has a correction. Please see:

Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery
Free
  1. J Cosnes1,
  2. I Nion-Larmurier1,
  3. L Beaugerie1,
  4. P Afchain1,
  5. E Tiret2,
  6. J-P Gendre1
  1. 1Service de Gastroentérologie et Nutrition, Hôpital Saint-Antoine, Paris, France
  2. 2Service de Chirurgie, Hôpital Saint-Antoine, Paris, France
  1. Correspondence to:
    Pr Jacques Cosnes
    Hôpital Saint-Antoine, 184 rue du Faubourg St-Antoine, 75571 Paris cedex 12, France; jacques.cosnessat.ap-hop-paris.fr

Abstract

Background/Aim: Immunosuppressants are now used much earlier in the course of Crohn’s disease; however their effect on the natural history of the disease, especially on the need for surgery, is not known. The aim of this study was to assess the evolution of the need for surgery in Crohn’s disease during the last 25 years.

Patients and Methods: The medical charts of 2573 patients were reviewed retrospectively. The use of immunosuppressants (azathioprine or methotrexate), the need for intestinal resection, and the occurrence of intestinal complications were assessed using Kaplan-Meier analysis in five consecutive cohorts of patients defined by the date of diagnosis of Crohn’s disease (1978–82; 1983–87; 1988–92; 1993–97; 1998–2002).

Results: In 565 patients seen in the authors’ unit within the first three months after diagnosis, characteristics of Crohn’s disease at diagnosis did not differ from one cohort to another. The five year cumulative probability to receive immunosuppressants increased from 0 in the 1978–82 cohort to 0.13, 0.25, 0.25, and 0.56 in the 1983–87, 1988–92, 1993–97, and 1998–2002 cohorts, respectively (p<0.001). Concomitantly, the cumulative risk of intestinal resection remained unchanged (from 0.35 to 0.34 at five years; p = 0.81). The cumulative risk of developing a stricturing or a penetrating intestinal complication remained also unchanged. Similar results were obtained in the 2008 patients seen during the same period who were referred to us more than three months after diagnosis.

Conclusion: Although immunosuppressants have been used more frequently over the last 25 years, there was no significant decrease of the need for surgery, or of intestinal complications of Crohn’s disease.

  • CD, Crohn’s disease
  • HR, hazard ratio
  • Crohn’s disease
  • surgery
  • immunosuppressants
  • natural history
View Full Text

Statistics from Altmetric.com

Supplementary materials

  • Complete Version

    Please note that Figure 2 was omitted from the published version. The complete version is available here as a downloadable PDF (printer friendly file).

    If you do not have Adobe Reader installed on your computer,
    you can download this free-of-charge, please Click here

     

    The error is much regretted.

    Files in this Data Supplement:

Footnotes

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Linked Articles

    • Digest
      Robin Spiller
    • CORRECTION
      BMJ Publishing Group Ltd and British Society of Gastroenterology